0.919
price up icon8.50%   0.072
pre-market  Pre-market:  .92   0.001   +0.11%
loading
iBio Inc stock is traded at $0.919, with a volume of 519.41K. It is up +8.50% in the last 24 hours and down -79.16% over the past month. iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.847
Open:
$0.86
24h Volume:
519.41K
Relative Volume:
0.68
Market Cap:
$8.54M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1386
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+3.27%
1M Performance:
-79.16%
6M Performance:
-67.75%
1Y Performance:
-46.57%
1-Day Range:
Value
$0.81
$0.9307
1-Week Range:
Value
$0.6358
$1.00
52-Week Range:
Value
$0.6358
$6.8908

iBio Inc Stock (IBIO) Company Profile

Name
Name
iBio Inc
Name
Phone
302-355-0650
Name
Address
600 Madison Avenue, Suite 1601, New York, NY
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
IBIO's Discussions on Twitter

Compare IBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IBIO
iBio Inc
0.919 8.54M 2.05M -23.15M -16.93M -6.6319
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

iBio Inc Stock (IBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
May-28-24 Initiated Chardan Capital Markets Buy
Nov-29-21 Initiated JMP Securities Mkt Outperform
Jan-22-21 Initiated Cantor Fitzgerald Overweight
Jun-26-20 Initiated Alliance Global Partners Buy

iBio Inc Stock (IBIO) Latest News

pulisher
Apr 25, 2025

iBio - The Pharma Letter

Apr 25, 2025
pulisher
Apr 25, 2025

AstralBio - The Pharma Letter

Apr 25, 2025
pulisher
Apr 24, 2025

iBio Inc (IBIO) expanding its growth trajectory ahead - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Monitoring iBio Inc (IBIO) after recent insider movements - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

In the Green: iBio Inc (IBIO) Closes at 0.70, Up/Down -17.43 from Previous Day - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Ibio Inc Enters Exclusive License Agreement With AstralBio - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

iBio Enters Licensing Agreement for Obesity Treatment - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

iBio Inc (IBIO) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Breaking down IBIO’s current quarter earnings estimates - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Revolutionary AI-Discovered Obesity Drug: iBio Licenses First-Ever Activin E Antibody in $28M Deal - Stock Titan

Apr 22, 2025
pulisher
Apr 22, 2025

Porch Group Inc (PRCH) Stock: A Year of Stock Market Dynamics - investchronicle.com

Apr 22, 2025
pulisher
Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia

Apr 16, 2025
pulisher
Apr 08, 2025

iBio Highlights Advancements in Obesity Antibody Programs - TipRanks

Apr 08, 2025
pulisher
Apr 07, 2025

iBio reports promising data on obesity treatment antibody By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

iBio reports promising data on obesity treatment antibody - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Where Do Analysts Think The iBio Inc (NASDAQ: IBIO) Is Going - stocksregister.com

Apr 07, 2025
pulisher
Apr 07, 2025

iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish - MSN

Apr 07, 2025
pulisher
Apr 07, 2025

Ibio reports preclinical results for antibodies in cardiometabolic and obesity pipeline - BioWorld MedTech

Apr 07, 2025
pulisher
Apr 07, 2025

Ibio IncOn Track For Regulatory Submission For Ibio-600 In Q1 2026 - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

iBio Reveals Promising Study Results for IBIO-600 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

iBio announces data from non-human primate PK study of IBIO-600 - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

Game-Changing Clinical Data: iBio's New Drug Combines Muscle Growth with Massive Weight Loss - Stock Titan

Apr 07, 2025
pulisher
Apr 06, 2025

Senior Mining ExecutiveFrederic Mercier-Langevin to Join Patriot Battery Metals - The Globe and Mail

Apr 06, 2025
pulisher
Apr 03, 2025

Hartford Insurance Group Inc.(The) [HIG] Officer makes an insider purchase of 1,144 shares worth 0.14 million. - knoxdaily.com

Apr 03, 2025
pulisher
Apr 02, 2025

Galaxy Digital UK Secures FCA License, Expanding Derivatives Trading Capabilities in London - The Globe and Mail

Apr 02, 2025
pulisher
Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025
pulisher
Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025
pulisher
Mar 04, 2025

IBIO Stock Price and Chart — NASDAQ:IBIO - TradingView

Mar 04, 2025
pulisher
Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025
pulisher
Mar 03, 2025

$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq

Mar 03, 2025
pulisher
Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

iBio Inc [IBIO] gain 106.12% so far this year. What now? - dbtnews.com

Feb 28, 2025
pulisher
Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025
pulisher
Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025
pulisher
Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025
pulisher
Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025
pulisher
Feb 20, 2025

iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire

Feb 20, 2025
pulisher
Feb 19, 2025

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Feb 19, 2025
pulisher
Feb 19, 2025

iBio Announces Transfer to Nasdaq Capital Market - TipRanks

Feb 19, 2025

iBio Inc Stock (IBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):